Skip to main content
HLB Pep Co., Ltd. logo

HLB Pep Co., Ltd. — Investor Relations & Filings

Ticker · 196300 ISIN · KR7196300008 KO Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2018-11-29 Regulatory Filings
Country KR South Korea
Listing KO 196300

About HLB Pep Co., Ltd.

http://hlbpep.co.kr/eng/main/

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)(5'-하이드록시-5-니트로-인디루빈-3'-옥심을 유효 성분으로 함유하는 유방암 치료제)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (Anygen) regarding the acquisition of a patent for a breast cancer therapeutic agent. It is filed as a 'voluntary disclosure' (자율공시) under the category of 'Other Management Matters' (기타 경영사항). Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory announcement of a corporate event, it falls under the 'Regulatory Filings' (RNS) category.
2018-11-29 Korean
기타경영사항(특허권취득)(자율공시)(신규한 엑세나타이드 유사체 및 그의 용도)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent for a new Exenatide analogue. It details the patent name, content, holder, and utilization plans. Since it does not fit into specific categories like financial reports, M&A, or governance, and is a standard regulatory disclosure of corporate events, it falls under the 'Regulatory Filings' category.
2018-11-27 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (Anygen) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). This is a standard material event disclosure required by the Korea Exchange (KRX) for significant contracts. Since it does not fit into specific categories like M&A, dividends, or share transactions, it falls under the general regulatory filing category.
2018-11-22 Korean
기타경영사항(특허권취득)(자율공시)(신규한 엑세나타이드 유사체 및 그의 용도)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent for a new Exenatide analogue. It details the patent name, content, and commercialization plans. Since it does not fit into specific categories like financial reports, board changes, or shareholder voting, and is a standard regulatory disclosure of corporate events, it falls under the 'Regulatory Filings' category.
2018-11-16 Korean
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the 3rd quarter of 2018 (제 19 기 3분기) for Anygen Co., Ltd. It contains detailed financial information, business operations, capital structure, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean
기타경영사항(특허권취득)(자율공시)(커큐민에 비하여 용해도가 향상된 커큐민―펩타이드 복합체 및 이의 제조방법)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company Anygen. It details the patent name, content, and utilization plan. Since this is a specific regulatory announcement regarding corporate operations that does not fit into financial reporting, dividend, or management change categories, it is classified as a general regulatory filing.
2018-11-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.